Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 60760-784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 60760-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

784-90 (Labetalol 784 90)

784-90 (Labetalol 784 90)
Label for Labetalol Hydrochloride 100 mg film-coated oral tablets. The label states a quantity of 90 tablets and includes various identifiers such as NDC 60760-784-90. It indicates the product is manufactured by Rubicon Research Private Limited and packaged by St. Mary's Medical Park Pharmacy located in Oro Valley, AZ. Storage instructions specify controlled room temperature (15°-30°C or 59°-86°F).*
FDA Label Image

Image (Labetalol Hydrochloride Tab Structure)

Image (Labetalol Hydrochloride Tab Structure)
Chemical structure of Labetalol Hydrochloride, showing its molecular composition including phenyl, hydroxyl, and amine groups along with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.